Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices
- PMID: 27862317
- PMCID: PMC5705048
- DOI: 10.1111/ctr.12875
Impact of insurance status on heart transplant wait-list mortality for patients with left ventricular assist devices
Abstract
Objectives: To test the hypotheses that receipt of Medicaid or Medicare (versus private insurance or self-pay) and low socioeconomic status (SES) leads to increased mortality and lower chances of transplantation among heart transplant (HTx) candidates with bridge to transplant left ventricular assist devices (BTT LVADs).
Background: Survival while awaiting HTx has improved with the use of BTT LVADs. However, it is unknown whether benefits extend uniformly across patient groups based on insurance status.
Methods: Data from the United Network of Organ Sharing (UNOS) registry between 2006 and 2015 were examined for first-time HTx candidates ≥18 and <65 years who had LVAD support while wait-listed. Multivariable survival analysis was conducted on competing outcomes of mortality and time to transplant stratified by insurance source at the time of listing. Additional covariates included demographic information and SES.
Results: A total of 4626 patients met inclusion criteria, with 3353 being used for multivariable analysis. A majority of patients (68%) underwent HTx during the study period. BTT LVAD wait-list mortality was found to be greater among Medicaid beneficiaries vs. private insurance (SHR 1.57, P<.05) and did not diminish with the inclusion of neighborhood SES. Transplantation as an outcome demonstrated no difference by insurance status.
Conclusion: Medicaid insurance status is associated with worse survival on the HTx wait-list among patients with BTT LVADs, although access to transplant was not different among insurance groups. The disparity is not reflective of SES in general and therefore points to other barriers inherent to Medicaid beneficiaries.
Keywords: Medicaid; bridge to transplant; left ventricular assist device; wait-list.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures


Similar articles
-
Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.Int J Cardiol. 2017 Mar 15;231:211-215. doi: 10.1016/j.ijcard.2016.12.148. Epub 2016 Dec 28. Int J Cardiol. 2017. PMID: 28043679
-
Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).Circ Heart Fail. 2016 Oct;9(10):e003215. doi: 10.1161/CIRCHEARTFAILURE.116.003215. Circ Heart Fail. 2016. PMID: 27758810 Free PMC article.
-
Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.Ann Thorac Surg. 2014 Sep;98(3):830-4. doi: 10.1016/j.athoracsur.2014.05.019. Epub 2014 Jul 31. Ann Thorac Surg. 2014. PMID: 25087934
-
[Proposal for updated listing criteria for heart transplantation and indications to implant of left ventricular assist devices].G Ital Cardiol (Rome). 2013 Feb;14(2):110-9. doi: 10.1714/1218.13523. G Ital Cardiol (Rome). 2013. PMID: 23389313 Review. Italian.
-
Current indications for heart transplantation and left ventricular assist device: a practical point of view.Eur J Intern Med. 2014 Jun;25(5):422-9. doi: 10.1016/j.ejim.2014.02.006. Epub 2014 Mar 16. Eur J Intern Med. 2014. PMID: 24641806 Review.
Cited by
-
Health Insurance and Left Ventricular Assist Device Outcomes: Focus on the Patient Journey, Not the Destination.Circ Heart Fail. 2021 May;14(5):e008558. doi: 10.1161/CIRCHEARTFAILURE.121.008558. Epub 2021 May 15. Circ Heart Fail. 2021. PMID: 33993720 Free PMC article. No abstract available.
-
Effects of socioeconomic status on clinical outcomes with ventricular assist devices.Clin Cardiol. 2018 Nov;41(11):1463-1467. doi: 10.1002/clc.23070. Epub 2018 Nov 20. Clin Cardiol. 2018. PMID: 30225924 Free PMC article.
-
Influence of Social Determinants of Health on Heart Failure Outcomes: A Systematic Review.J Am Heart Assoc. 2023 Feb 7;12(3):e026590. doi: 10.1161/JAHA.122.026590. Epub 2023 Jan 25. J Am Heart Assoc. 2023. PMID: 36695317 Free PMC article.
-
Racial Disparity in Liver Transplantation Listing.J Am Coll Surg. 2021 Apr;232(4):526-534. doi: 10.1016/j.jamcollsurg.2020.12.021. Epub 2021 Jan 12. J Am Coll Surg. 2021. PMID: 33444709 Free PMC article.
-
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27. Circulation. 2025. PMID: 39866113 Review.
References
-
- Mozaffarian D, Benjamin EJ, Go AS, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation. 2016;133:447–454. - PubMed
-
- Miller LW, Guglin M. Patient selection for ventricular assist devices: a moving target. J Am Coll Cardiol. 2013;61:1209–1221. - PubMed
-
- Lund LH, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: thirty-second official adult heart transplantation report–2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1244–1254. - PubMed
-
- Allen JG, Weiss ES, Arnaoutakis GJ, et al. The impact of race on survival after heart transplantation: an analysis of more than 20,000 patients. Ann Thorac Surg. 2010;89:1956–1963. - PubMed
-
- Allen JG, Weiss ES, Arnaoutakis GJ, et al. Insurance and education predict long-term survival after orthotopic heart transplantation in the United States. J Heart Lung Transplant. 2012;31:52–60. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous